An interventional study of Clinically Designed Improvisatory Music in Alzheimer Disease, sponsored by Northwestern University. Enrolling by invitation at 1 site in United States. Open to participants aged 55 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-10.
Sponsored by Northwestern University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Alzheimer Disease by Northwestern University — 5 open to participants now, 6 under way, none of them phase 3. Alzheimer Disease · Northwestern University.
Among the 16 studies in Alzheimer Disease by Northwestern University, this one is the 12th largest by planned enrollment of the 15 interventional ones that give a count, is one of 2 that started in 2023, is one of 14 with no phase, and was the 9th registered.
3,972 studies on the registry are indexed under Alzheimer Disease; 930 are open to participants now.
Browse Alzheimer Disease studies →5 of the 16 studies in Alzheimer Disease by Northwestern University are open now, in 1 country. Recruiting first, the newest first:
Northwestern University · Sites in United States
Ages 55+
Northwestern University · Sites in United States
Ages 60–90
Northwestern University · Sites in United States
Ages 18+ · Healthy volunteers
Northwestern University · Sites in United States
Ages 21+ · Healthy volunteers
By country, each count listing its studies:
Of the 645 Alzheimer Disease studies recruiting now, 282 (44%) set no upper age limit and 57 (9%) stop at 75 or younger; 34 take children under 18; 288 take healthy volunteers.
This study: 55 Years to 100 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2015; this study’s year is marked. 2 started in 2023.
This study's planned enrollment of 30 is below the median of 70 across 3,022 interventional studies indexed under Alzheimer Disease.
Median enrollment 105 across the 15 interventional studies, 0 across the 1 observational. Of the 8 that completed or were terminated, 7 (88%) have results posted.
This tab as a report to print or save as PDF → With an account.
Northwestern University is the lead sponsor of 1,424 studies on the registry; 199 are open to participants now.
Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.
4 of the studies in Alzheimer Disease by Northwestern University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07775625Northwestern UniversityCentral Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory Music | 2026-12-15 |
| NCT05477862Northwestern UniversityNeural Mechanisms of Clinically Designed Improvisatory Music for Alzheimer's Disease | 2026-12-15 |
| NCT06112860Northwestern UniversityOTC Hearing Aid and MCI | 2026-12-31 |
| NCT05607732Northwestern UniversityPrimary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial | 2027-04-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 16 studies in Alzheimer Disease by Northwestern University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Clinically Designed Improvisatory Music (CDIM) is a form of improvised music based on calm-inducing sound parameters which brought relief to our cohort of neurology patients. As a direct sound-based approach, CDIM does not rely on autobiographical memory and may have wider applicability and generalizability. We wish to examine if CDIM decreases anxiety in 15 cognitively healthy individuals and 15 Alzheimer Disease patients with anxiety (AD-A).
The goal of this study is to identify the neural mechanisms of induced calmness through live clinically designed improvisatory music (CDIM) in cognitively healthy individuals and persons with Alzheimer's dementia suffering from agitation. This study is novel as most music interventions for dementia use familiar music and the underlying neural mechanism of calmness induced by music is not well known. We plan to investigate changes in 3 major large-scale brain networks using functional magnetic resonance imaging (fMRI). The major questions we plan to answer are as follows: 1. How does improvisatory music change the connectivity within brain emotion related networks in neurotypical individuals? 2. Does improvisatory music induce a state of calmness in individuals with Alzheimer's dementia and how? Based on objective evidence provided by this study we can justify further usage of music for patients with Alzheimer's, in particular, in the form of improvisation.
Inclusion Criteria:
Cognitively healthy individuals
Cognitively healthy control participants evaluated through the Northwestern Mesulam Center. BAI > 8.
Exclusion Criteria: hearing loss
This group will similarly be recruited through the Mesulam Center. All individuals recruited by the research Core at the center are well characterized tests standardized across all NIH funded Alzheimer Centers across the nation. Individuals with mild to moderate neurocognitive disorder due to AD will have an greater than >15 and Clinical Dementia Rating (CDR) between 0.5 and 2.. They will also have a history of neurocognitive-related agitation/anxiety, and a Beck Anxiety Index (BAI) or Rating for Anxiety in Dementia (RAID) greater than 8, suggestive of at least a mild level of anxiety.
Exclusion criteria: MMSE\<15, CDR>2, hearing loss
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Behavioral: Clinically Designed Improvisatory Music
Behavioral: Clinically Designed Improvisatory Music
Clinically Designed Improvisatory Music (CDIM) is a form of improvised music based on calm-inducing sound parameters which brought relief to our cohort of neurology patients.
Change in Neuropsychiatric Inventory (NPI) [NPI-1: pre-intervention; NPI-2: post-intervention]
Change in NPI (NPI-2 minus NPI-1)
Time frame: Through study completion (3 years)
Change in Beck Anxiety Inventory [BAI-1: pre-intervention; BAI-2: post-intervention]
Change in BAI (BAI-2 minus BAI-1)
Time frame: Through study completion (3 years)
Change in Systolic Blood Pressure [SBP-1: pre-intervention; SBP-2: post-intervention]
Change in SBP (SBP-2 minus SBP-1)
Time frame: Through study completion (3 years)
Change in Heart rate [HR-1: pre-intervention; HR-2: post-intervention]
Change in HR (HR-2 minus HR-1)
Time frame: Through study completion (3 years)
Change Respiratory Rate [RR-1: pre-intervention; RR-2: post-intervention]
Change in RR (RR-2 minus RR-1)
Time frame: Through study completion (3 years)
Change in Skin conductance [SC-1: pre-intervention; SC-2: post-intervention]
Change in SC (SC-2 minus SC-1)
Time frame: Through study completion (3 years)
Change in Resting state functional connectivity MRI
Functional Connectivity within three resting state networks: Change in Default Network (DN), Change in Salience Network (SN), and Change in Reward Network (RN).
Time frame: Through study completion (3 years)
Plan to share: No
Started Sep 2023 (actual). Primary completion is estimated for Dec 2026, 39 months after the start.
Of 887 non-industry interventional studies with no phase under Alzheimer Disease, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 51. This study's planned 39 months is above that.
Counting every sponsor, half of 964 studies reached it within 29 months; a quarter within 15 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.